ORCID as entered in ROS
https://orcid.org/0000-0001-7250-5217
Select Publications
Journal articles
, 1993, 'Sequence of the mouse fibronectin-encoding gene promoter region', Gene, 137, pp. 353 - 354, http://dx.doi.org/10.1016/0378-1119(93)90036-3
Conference Papers
, 2020, 'RECOGNISING AND REWARDING TEACHING EXCELLENCE IN HIGHER EDUCATION USING AN EPORTFOLIO', in International Conference on Education and New Learning Technologies, IATED Academy, pp. 244 - 248, presented at
, 2018, 'Preparing Future Career Ready Professionals: A Portfolio Process to Develop Critical Thinking Using Digital Learning and Teaching', in Advances in Intelligent Systems and Computing, pp. 702 - 707, http://dx.doi.org/10.1007/978-3-319-73210-7_82
, 2017, 'TEAMWORK SKILLS BUILDING AND REFLECTIVE PRACTICE IN THE MEDICAL SCIENCES USING EPORTFOLIO LEARNING AND AUTHENTIC ASSESSMENT', in Chova LG; Martinez AL; Torres IC (eds.), 9TH INTERNATIONAL CONFERENCE ON EDUCATION AND NEW LEARNING TECHNOLOGIES (EDULEARN17), IATED-INT ASSOC TECHNOLOGY EDUCATION & DEVELOPMENT, SPAIN, Barcelona, pp. 2086 - 2086, presented at
, 2017, 'Abstract LB-080: The histone methyltransferase DOT1L promotes neuroblastoma by regulating gene transcription', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1538-7445.am2017-lb-080
, 2017, 'Supporting critical thinking through digital learning and teaching: A portfolio process', in Proceedings of the European Conference on e-Learning, ECEL, pp. 461 - 465
, 2013, 'Linc367, a novel long intergenic noncoding RNA, up-regulates N-Myc gene expression and neuroblastoma cell proliferation', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, NETHERLANDS, Amsterdam, pp. S356 - S356, presented at
, 2013, 'Enhancement of scientific research and communication skills using assessment and ePortfolio in a third year pathology course', in 30th Annual conference on Australian Society for Computers in Learning in Tertiary Education, ASCILITE 2013, pp. 711 - 723
, 2012, 'Impact of integrated adaptive tutorials on learning in pathology', in Tubbs SR (ed.), Abstracts of the 2012 meeting of the Australian and New Zealand association of clinical anatomists. Clinical Anatomy 26: 641–660., Wiley, Sydney, Australia, pp. 641 - 660, presented at
, 2012, 'Eportfolios in the sciences: The role of reflection as students build professional skills and career readiness', in ASCILITE 2012 - Annual conference of the Australian Society for Computers in Tertiary Education
, 2011, 'MUSCULOSKELETAL BREAKDOWN DUE TO CANCER CACHEXIA: MOLECULAR AND MORPHOLOGICAL EFFECTS', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, AUSTRALIA, Gold Coast, pp. S596 - S597, presented at
, 2011, 'A Morphological Characterization of Cancer induced Cardiomyopathy Independent of Chemotherapeutic Intervention', in Heart Lung Circulation
, 2011, 'Cancer-induced cardiomyopathy: A series of maladaptive responses.', in Eur. J. Cardiol. Suppl
, 2011, 'Cardiac and skeletal muscle biomarker profiling in cancer induced cachexia: a comparison', in Heart Lung Circulation
, 2011, 'J. Sarcopenia and Cachexia', Milan, presented at
, 2011, 'Musculoskeletal Breakdown due to Cancer Cachexia: Molecular and Morphological Effects.', in Osteoporosis Int., Springer, pp. 22: S596-S597 Suppl. 4,
, 2011, 'Potential novel molecular regulators of cancer cachexia-induced cardiomyopathy.', in Heart Lung Circulation
, 2010, 'MEF2C: A Novel Regulator of Cancer-Induced Skeletal Muscle Wasting', Sydney, Australia, pp. p68, presented at
, 2009, 'Cancer Cachectic effects on bone; an analysis of molecular regulators and morphological changes', Barcelona, Spain, presented at
, 2009, 'Tumour-mediated Effects on Circadian Rhythm Gene Expression in Skeletal Muscle', Barcelona, Spain, presented at
, 2005, 'PSF and p54nrb/NonO modulate muscle fibre-specific gene transctiption', in Mechanisms of Development, Elsevier Science BV, Amsterdam, Netherlands, pp. S49 - S49, - , http://dx.doi.org/10.1016/j.mod.2005.06.010
, 2005, 'The role of MusTRD/GTF2IRD1 in neurodevelopment, Williams-Beuren syndrome and anterior-posterior axis formation', in Mechanisms of Development, Elsevier Science BV, Amsterdam, Netherlands, pp. 122:S117-S117
, 2004, 'A GMustrd/Gtf2ird1: Gene that Regulates Behaviour and Body Plan', in Australian Health and Medical Research Congress, Sydney, NSW, pp. 118, Sydney, NSW
, 2000, 'VDR-Alien: A Novel, DNA-Selective, Vitamin D3 Receptor-Corepressor Partnership', in Norman AW; Bouillon R; Thomasset M (eds.), Proceedings of the Eleventh Workshop on Vitamin D Vitamin D, Chemistry, Biology and Clinical Applications of the Steroid Hormone,, Nashville, USA, pp. 309 - 312, Nashville, USA
, 1997, 'Vitamin D Receptor-Mediated Transrepression of Retinoid Signalling Occurs via a Novel Retinoic Acid Response Element Identified in the Human Tumour Necrosis Factor Ą Receptor Type I Gene.', in Norman AW; Bouillon R; Thomasset M (eds.), Proceedings of the Tenth Workshop on Vitamin D Vitamin D, Chemistry, Biology and Clinical Applications of the Steroid Hormone, Strasbourg, France, pp. 326 - 327, Strasbourg, France
Conference Posters
, 2016, 'Reflective practice for enabling future employability skills development in second year science students undertaking Histology and Pathology courses at UNSW', Canberra, Australian Capital Territory, presented at 13th Annual Conference of the Australian and New Zealand Association of Clinical Anatomists (ANZACA 2016), Canberra, Australian Capital Territory, 07 December 2016 - 09 December 2016
, 2014, 'Development and deployment of interactive online practical elements from biomedical practical lessons in Phase 1 Medicine at UNSW: What have we learned?', UNSW Australia, presented at UNSW Learning and Teaching Forum, UNSW Australia, 09 May 2014 - 09 May 2014
Conference Presentations
, 2020, 'Remote delivery of a digitized course; success at time of crisis', presented at Teaching and Learning Forum, UNSW, UNSW Sydney
, 2018, 'Using narratives to teach Pathology', presented at Teaching and Learning Forum, UNSW, UNSW Sydney
, 2013, 'Oral Communications: The poor relation in the literacies nexus', presented at The Eleventh Biennial Conference of the Association for Academic Language and Learning,, Melbourne, 13 November 2013 - 15 November 2013
, 2009, 'Collaborative approach to enhancing student learning in a second-year pathology course', presented at 9th Biennial Conference of the Association for Academic Language and Learning, Brisbane, 26 November 2009 - 27 November 2009, http://www.uq.edu.au/aall/docs/Jones-Polly-Handout.pdf
Conference Abstracts
, 2019, 'Abstract 5209: Efficacious targeting of TERT oncogene rearrangement with BET bromodomain inhibitor and proteasome inhibitor combination therapy', in Molecular and Cellular Biology / Genetics, American Association for Cancer Research, presented at Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA, http://dx.doi.org/10.1158/1538-7445.sabcs18-5209
, 2019, 'Efficacious targeting of TERT oncogene rearrangement with BET bromodomain inhibitor and proteasome inhibitor combination therapy', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, GA, Atlanta, Vol. 79, presented at Annual Meeting of the American-Association-for-Cancer-Research (AACR), GA, Atlanta, 29 March 2019 - 03 April 2019, http://dx.doi.org/10.1158/1538-7445.AM2019-5209
, 2017, 'EMENTORING TO SUPPORT AND ENABLE RESEARCH INTEGRATED LEARNING USING AUTHENTIC ASSESSMENT IN A THIRD YEAR UNDERGRADUATE SCIENCE COURSE IN PATHOLOGY AT A RESEARCH INTENSIVE UNIVERSITY', in EDULEARN17 Proceedings, presented at 9th International Conference on Education and New Learning Technologies
, 2015, 'The role of DOT1L in neuroblastoma', in EUROPEAN JOURNAL OF CANCER, ELSEVIER SCI LTD, AUSTRIA, Vienna, Vol. 51, pp. S11 - S12, presented at European Cancer Congress, AUSTRIA, Vienna, http://dx.doi.org/10.1016/S0959-8049(16)30037-5
Preprints
, 2022, Effect of insulin insufficiency on ultrastructure and function in skeletal muscle, , http://dx.doi.org/10.1101/2022.12.18.520900
Other
, 2023, Data from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.c.6530307.v1
, 2023, Data from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.c.6530307
, 2023, Supplementary Figure S1 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479852
, 2023, Supplementary Figure S1 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479852.v1
, 2023, Supplementary Figure S2 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479849.v1
, 2023, Supplementary Figure S2 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479849
, 2023, Supplementary Figure S3 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479846.v1
, 2023, Supplementary Figure S3 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479846
, 2023, Supplementary Figure S4 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479843
, 2023, Supplementary Figure S4 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479843.v1
, 2023, Supplementary Figure S5 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479840.v1
, 2023, Supplementary Figure S5 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479840
, 2023, Supplementary Figure S6 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479837.v1
, 2023, Supplementary Figure S6 from Targeted Therapy of <i>TERT</i>-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy, , http://dx.doi.org/10.1158/1078-0432.22479837
Filter by type
https://orcid.org/0000-0001-7250-5217